戻る Agenda
Postmarket Surveillance Issues for Medical Devices
Session Chair(s)
Kirsten H. Paulson, MS, RAC
Pfizer, Inc., United States
A Global Perspective on Strengthening the Postmarket Surveillance for Medical Devices
Learning Objective : Explain how FDA’s National Postmarket Strategy is being implemented; Discuss Device Registry Best Practices; Describe status of Postapproval Studies program and data transparency issues.
Speaker(s)
A Global Perspective on Strengthening the Postmarket Surveillance for Medical Devices
Colin R.W. Hayward, FFPM
Premier Research Group Ltd., United Kingdom
Chief Medical Officer
Panelist
Kirsten H. Paulson, MS, RAC
Pfizer, Inc., United States